Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

DTRA Invests in Distance Learning System for Clinician Select Agent Training

by Global Biodefense Staff
November 14, 2016
Online Medical Training

Online Medical TrainingThe Defense Threat Reduction Agency has announced intentions to award a sole-source contract to the British Medical Journal (BMJ) to deliver training on infectious diseases related to Select Agents and Toxins for clinicians in Cooperative Biological Engagement Program (CBEP) partner-countries.

BMJ has developed a commercially available platform that provides training to clinical practitioners and specialists in the form of online modules to supplement their existing medical training with the best available, world-renowned, and peer- reviewed clinical data.

This procurement is intended to acquire the services of the BMJ to adapt their existing system to complete their comprehensive offering of training material on Select Agents and Toxins, which already contains approximately 30% of Select Agent data.

Since CBEP is adapting their platform, the BMJ is expected to absorb the cost of updating all of the material once development is complete. In addition, CBEP plans to procure standalone standardized educational material which will be considered Government Furnished Information (GFI) that may be distributed to partner nations.

“Correct clinical diagnosis of infectious dieases caused by Select Agents is critical for early disease detection. Given that symptoms of infectious diseases caused by Select Agents often present as common endemic clinical conditions, there is a mission need to deploy clinical/medical training programs that help our partner nations to identify and differentially diagnose diseases of security concern,” states the announcement. “This will ultimately improve the accuracy of diagnoses and downstream reporting, therefore providing fidelity to decision making in the event that a disease of security concern emerges.”

The current CBEP training model requires contractor personnel to travel OCONUS for several days in order to conduct classroom-based training events.  Based on recent studies conducted by National Center for Biotechnology Information, National Institute of Health (NIH) and United States Agency for International Development, this type of training is not indicative of effective information uptake especially for practicing clinicians who are limited in their schedule availability.

The same studies have recommended distance learning and on-the-job training as a much more effective tool to stay abreast of the most recent medical developments for accurate diagnoses. As a result, CBEP is initiating a new training paradigm by utilizing an existing distance-learning platform to supplement practicing clinicians’ medical knowledge and training them in how to properly diagnose infectious diseases of security concern.

The estimated total contract dollar value is $3.7M. It is likely that the base period of performance will begin in late FY16. CBEB expects to use a combination of FY16 and FY17 funds for the base period.

Tags: AwardsCooperative Threat ReductionDefense Threat Reduction AgencySelect Agents

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC